ASC-2 is a recently isolated transcriptional cointegrator molecule, which is amplified in human cancers and stimulates transactivation by nuclear receptors, AP-1, nuclear factor kappaB (NFkappaB), serum response factor (SRF), and numerous other transcription factors. ASC-2 contained two nuclear receptor-interaction domains, both of which are dependent on the integrity of their core LXXLL sequences. Surprisingly, the C-terminal LXXLL motif specifically interacted with oxysterol receptor LXRss, whereas the N-terminal motif bound a broad range of nuclear receptors. These interactions appeared to be essential because a specific subregion of ASC-2 including the N- or C-terminal LXXLL motif acted as a potent dominant negative mutant with transactivation by appropriate nuclear receptors. In addition, the autonomous transactivation domain (AD) of ASC-2 was found to consist of three separable subregions; i.e. AD1, AD2, and AD3. In particular, AD2 and AD3 were binding sites for CREB binding protein (CBP), and CBP-neutralizing E1A repressed the autonomous transactivation function of ASC-2. Furthermore, the receptor transactivation was not enhanced by ASC-2 in the presence of E1A and significantly impaired by overexpressed AD2. From these results, we concluded that ASC-2 directly binds to nuclear receptors and recruits CBP to mediate the nuclear receptor transactivation in vivo.
Pubmed ID: 11158331 RIS Download
Mesh terms: Amino Acid Sequence | Animals | Binding Sites | CREB-Binding Protein | Cell Line | Escherichia coli | Gene Expression | Glutathione Transferase | HeLa Cells | Humans | Intracellular Signaling Peptides and Proteins | Mice | Nuclear Proteins | Nuclear Receptor Coactivators | Peptide Fragments | Plasmids | Polymerase Chain Reaction | Protein Structure, Secondary | Receptors, Cytoplasmic and Nuclear | Receptors, Steroid | Receptors, Thyroid Hormone | Recombinant Fusion Proteins | Saccharomyces cerevisiae | Structure-Activity Relationship | Trans-Activators | Transcription Factors | Transcriptional Activation | Transfection | beta-Galactosidase
Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.